| 1 |
Zhang P, Liu Z, Fan H, Shi T, Han X, Suo C, Chen X, Zhang T. Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2023;35:294-301. [PMID: 36708301 DOI: 10.1097/MEG.0000000000002488] [Reference Citation Analysis]
|
| 2 |
Lu R, Liu Y, Hong T. Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review. Diabetes Obes Metab 2023. [PMID: 36775938 DOI: 10.1111/dom.15014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Chen F, Liu Y, Li Q, Wang F. Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis/hepatitis B - induced hepatic injury. Clin Res Hepatol Gastroenterol 2023;47:102056. [PMID: 36427780 DOI: 10.1016/j.clinre.2022.102056] [Reference Citation Analysis]
|
| 4 |
Yuri M, Nishimura T, Tada T, Yoshida M, Fujiwara A, Kawata S, Yoshihara K, Yoshioka R, Ota S, Nakano R, Yuri Y, Takashima T, Aizawa N, Ikeda N, Shiomi H, Ide YH, Enomoto H, Yasuhiro F, Yano H, Iijima H. Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis. Hepatol Res 2022;52:1009-19. [PMID: 36018852 DOI: 10.1111/hepr.13831] [Reference Citation Analysis]
|
| 5 |
He F, Xia Z, Wang H, Zhu J, Hu L. Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B. Evid Based Complement Alternat Med 2022;2022:1673453. [PMID: 35774746 DOI: 10.1155/2022/1673453] [Reference Citation Analysis]
|
| 6 |
Luo Y, Dong Z, Qi S, Li W. Application of Health Education Model Based on Theory of Behavior Change in Nursing Care of Patients with Chronic Hepatitis B. Journal of Nanomaterials 2022;2022:1-7. [DOI: 10.1155/2022/1982554] [Reference Citation Analysis]
|
| 7 |
Tao X, Chen L, Zhao Y, Liu Y, Shi R, Jiang B, Mi Y, Xu L. A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease. Front Med 2022;9:862879. [DOI: 10.3389/fmed.2022.862879] [Reference Citation Analysis]
|
| 8 |
Shi X, Li N. Research Progress in Infectious Agents of Malignant Tumors. Progress in China Epidemiology 2022. [DOI: 10.1007/978-981-19-2199-5_10] [Reference Citation Analysis]
|
